Jupiter Neurosciences, Inc.
JUNS
$3.20
-$0.08-2.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 29.41% | -14.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 29.41% | -14.22% | |||
| Cost of Revenue | 45.28% | 767.22% | |||
| Gross Profit | -45.99% | -1,420.31% | |||
| SG&A Expenses | 38.15% | -43.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 39.64% | -29.99% | |||
| Operating Income | -39.73% | 30.11% | |||
| Income Before Tax | -10.30% | 19.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.30% | 19.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.30% | 19.92% | |||
| EBIT | -39.73% | 30.11% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 7.01% | 13.28% | |||
| Normalized Basic EPS | -15.38% | 21.79% | |||
| EPS Diluted | 7.01% | 13.69% | |||
| Normalized Diluted EPS | -15.38% | 21.79% | |||
| Average Basic Shares Outstanding | 18.61% | -7.66% | |||
| Average Diluted Shares Outstanding | 18.61% | -7.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||